Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind, parallel-group, randomised trial

Study reported reductions from baseline in Richmond Agitation Sedation Scale scores in haloperidol escalation group (n=10; −3.6), haloperidol/chlorpromazine rotation group (11; −3.3), and haloperidol/chlorpromazine combination group (10; −3.0), with no difference among groups.

SPS commentary:



The Lancet Oncology